Galaxy Surfactants Ltd. signed a Partnership Growth Charter with Unilever to accelerate next-generation surfactant technologies. The collaboration focuses on bio-based alternatives and lower-carbon technologies for future growth.
Galaxy Surfactants delivered a strong Q1FY27 performance with consolidated revenue growing 39.4% YoY and EBITDA surging 86.9%. Growth was driven by a return to double-digit volumes in India and Specialty Care recovery.
Galaxy Surfactants reported Q1 FY27 revenue of ₹1,785.2 crore and EBITDA of ₹252.5 crore, highlighting strong earnings momentum for the quarter ended June 2026.
Galaxy Surfactants Ltd held its 40th Annual General Meeting on August 12, 2026. Shareholders considered financial statements, re-appointed a director, and approved the final dividend.
Galaxy Surfactants will hold a board meeting on August 13, 2026, to approve the company's unaudited financial results for the quarter ended June 30, 2026.
Galaxy Surfactants Limited has granted 8,400 stock options under its Performance Stock Option Plan 2025. The options carry an exercise price of Rs. 10 per share.
Galaxy Surfactants scheduled its AGM for August 12, 2026. Agenda includes adopting financial statements, re-appointing a director, and approving a Rs. 22 dividend.
Galaxy Surfactants Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and sustainability initiatives.
Galaxy Surfactants informed that the record date for the FY 2025-26 final dividend will be July 31, 2026. The dividend will be paid pending AGM approval.
Galaxy Surfactants reports Q4FY26 EBITDA at ₹122cr with EBITDA/MT of ₹20,114. India volumes grew 8% YoY, while AMET region declined 15% due to supply chain disruptions.
Galaxy Surfactants recommended a final dividend of ₹22 per share for FY2025-26. Payment is scheduled by September 10, 2026, pending shareholder approval.
Galaxy Surfactants reported FY26 revenue of ₹5,270.4 Crore and PAT of ₹267.4 Crore. Performance remained resilient despite global supply chain disruptions and geopolitical conflicts.
Galaxy Surfactants reports FY26 revenue of ₹5,270.4 Cr, up 24% YoY. EBITDA declined 2.5% to ₹497.4 Cr with margins contracting to 9.4% due to geopolitical disruptions and input cost volatility.
Galaxy Surfactants approved FY26 audited financial results and recommended a ₹22 per share dividend. Standalone annual profit after tax stood at ₹152.04 Crore.
Galaxy Surfactants Limited granted 10,235 stock options under its PSOP 2025 scheme. The options vest after FY 2028-29 at an exercise price of ₹10 per share.
Galaxy Surfactants Ltd has scheduled a Board Meeting on May 14, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a final dividend. The company's trading window remains closed until May 16, 2026.
Galaxy Surfactants Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The certificate confirms the dematerialisation and cancellation of share certificates by its Registrar, MUFG Intime India Pvt. Ltd.